ALR Share Price

Open 38.02 Change Price %
High 39.22 1 Day 1.12 2.95
Low 37.85 1 Week -0.01 -0.03
Close 39.13 1 Month -0.82 -2.05
Volume 1380619 1 Year -11.56 -22.81
52 Week High 51.00
52 Week Low 31.47
ALR Important Levels
Resistance 2 40.40
Resistance 1 39.88
Pivot 38.73
Support 1 38.38
Support 2 37.86
NYSE USA Most Active Stocks
BAC 23.12 0.78%
BAC 23.12 0.78%
BAC 23.12 0.78%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
CYH 9.54 13.57%
SB 1.83 12.27%
SB 1.83 12.27%
FNP 35.24 12.02%
FNP 35.24 12.02%
SVU 3.74 11.98%
SVU 3.74 11.98%
THC 18.28 11.74%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Alere Inc. (NYSE: ALR)

ALR Technical Analysis 1.5
As on 24th Mar 2017 ALR Share Price closed @ 39.13 and we RECOMMEND Sell for LONG-TERM with Stoploss of 40.40 & Buy for SHORT-TERM with Stoploss of 38.97 we also expect STOCK to react on Following IMPORTANT LEVELS.
ALR Target for March
1st Target up-side 40.71
2nd Target up-side 42.4
3rd Target up-side 44.09
1st Target down-side 35.89
2nd Target down-side 34.2
3rd Target down-side 32.51
ALR Other Details
Segment EQ
Market Capital 1603132288.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.alere.com
ALR Address
ALR
51 Sawyer Road
Suite 200
Waltham, MA 02453
United States
Phone: 781-647-3900
ALR Latest News
Interactive Technical Analysis Chart Alere Inc. ( ALR NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Alere Inc.
ALR Business Profile
Alere Inc. provides diagnostics and services for cardiology, infectious disease, toxicology, and diabetes in the United States and internationally. The company operates in three segments: Professional Diagnostics, Health Information Solutions, and Consumer Diagnostics. The Professional Diagnostics segment provides diagnostic test products and other in vitro diagnostic tests to medical professionals and laboratories for detection of diseases and conditions in the areas of cardiology, infectious diseases, toxicology, diabetes, oncology, and women’s health, as well as offers connected device technologies. The Health Information Solutions segment offers integrated programs and services focused on wellness, disease and condition management, productivity enhancement, and informatics. This segment’s health improvement programs comprise patient self-testing, condition and case management, women’s and children’s health, and health and wellness programs. The Consumer Diagnostics segment provides products for over-the-counter pregnancy and fertility/ovulation test markets; and over-the-counter drug tests for at-home testing and cholesterol monitoring under the First Check brand name, as well as vaginal gel for the treatment of bacterial vaginosis. Alere Inc. markets its professional diagnostic products to hospitals, reference laboratories, physician offices, and other point-of-care settings through its sales force and distribution networks; health information solutions primarily to commercial and governmental health plans, self-insured employers, government and governmental programs, pharmaceutical companies, and physicians through sales force and channel partners; and consumer drug testing products through retail drug stores, drug wholesalers, groceries, and mass merchandisers. The company was formerly known as Inverness Medical Innovations, Inc. and changed its name to Alere Inc. in July 2010. Alere Inc. was founded in 2001 and is headquartered in Waltham, Massachusetts.